Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic surveillance has revealed thousands of alterations in structural and non-structural proteins. However, by the end of 2020, viral ...
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...
Post-translational modifications contribute to the structure, function, and efficacy of the therapeutic antibody. The extent to which the antibody is modified and the location of the modifications all ...
BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire ...
Antibodies, also known as immunoglobulins, are specialized proteins produced by the immune system to identify and neutralize foreign invaders, such as viruses, bacteria, and other pathogens. They are ...
BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire ...
The burden of drafting patent applications with sufficient support for antibody claims is not likely to lessen any time soon. The courts and the scientific community are in agreement that antibody ...
In drug development, the term “modality” refers to the category of therapeutic based on its chemical or biological nature. Small molecules are the most established modality, known for their chemical ...
Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback